| 000 | 01265 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514073243.0 | ||
| 264 | 0 | _c20030902 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0950-222X | ||
| 024 | 7 |
_a10.1038/sj.eye.6700586 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonaldson, M | |
| 245 | 0 | 0 |
_aMedical treatment of diabetic retinopathy. _h[electronic resource] |
| 260 |
_bEye (London, England) _cJul 2003 |
||
| 300 |
_a550-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdrug therapy |
| 650 | 0 | 4 | _aGlycosylation |
| 650 | 0 | 4 |
_aGrowth Substances _xtherapeutic use |
| 650 | 0 | 4 |
_aHemostasis _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xprevention & control |
| 650 | 0 | 4 |
_aHypertension _xprevention & control |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSorbitol _xmetabolism |
| 700 | 1 | _aDodson, P M | |
| 773 | 0 |
_tEye (London, England) _gvol. 17 _gno. 5 _gp. 550-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.eye.6700586 _zAvailable from publisher's website |
| 999 |
_c12636394 _d12636394 |
||